Suspension for injection.Uses
For the active immunisation of pigeons against clinical signs caused by a virulent PPMV-1 infection. The vaccine has been shown to reduce virus excretion after challenge significantly.
Onset of immunity: 4 weeks after primary vaccination. A duration of immunity of 1 year has been demonstrated.
Each animal should be given 0.25 ml of vaccine by subcutaneous injection into the lower back part of the neck. Ensure that vaccination equipment is clean and sterile before use.
Advice on correct administration
Allow the vaccine to reach ambient temperature (15-25°C) before use. Shake well before use. Use sterile syringes and needles. Birds can be vaccinated from five weeks of age. Annual revaccination is recommended.
Only healthy birds should be vaccinated.
Vaccination within 4 weeks of the start of the breeding season is not recommended. No information is available on the safety of this product during the reproduction period.
To the user This product contains mineral oil. Accidental injection/self injection could result in severe pain and swelling, particularly if injected into a joint or finger, and in rare cases could result in the loss of the affected finger if prompt medical attention is not given. If you are accidentally injected with the product, seek prompt medical advice even if only a very small amount is injected and take the package insert with you. If pain persists for more than 12 hours after medical examination, seek medical advice again.
To the physician This product contains mineral oil. Even if small amounts have been injected, accidental injection with this product may cause intensive swelling, which may, for example, result in ischaemic necrosis and even the loss of a digit. Expert, PROMPT, surgical attention is required and may necessitate early incision and irrigation of the injected area, especially where there is involvement of a finger pulp or tendon.
No information is available on the safety and efficacy of this vaccine when used with any other veterinary medicinal product. A decision to use this vaccine before or after any other veterinary medicinal product therefore needs to be made on a case by case basis. Do not mix with any other veterinary medicinal product.
A good immune response is reliant on the reaction of an immunogenic agent and a fully competent immune system. Immunogenicity of the vaccine antigen will be reduced by poor storage or inappropriate administration. Immunocompetence of the animal may be compromised by a variety of factors including poor health, nutritional status, genetic factors, concurrent drug therapy and stress. Under certain conditions, for example extreme disease pressure and variant challenge, fully immune birds may succumb to disease. Therefore, successful vaccination may not be synonymous with full protection in the face of a disease challenge.
For animal treatment only. Keep out of the reach and sight of children.
Store in a refrigerator (2°C to 8°C). Do not freeze.
Use immediately after opening.
Any unused product or waste material should be disposed of in accordance with national requirements.
6.25 ml (25 dose), 20 ml (80 dose) and 50 ml (200 dose) bottles.
Not all presentations may be marketed.